Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Melanoma 2Carcinoma, Hepatocellular 2Turcot syndrome 1Recurrence 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Mouth Neoplasms 1Malignant Ascites 1Liver Neoplasms 1Head and Neck Neoplasms 1Glioma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Small Cell 1Carcinoma, Endometrioid 1Carcinoma 1

Interventions

pembrolizumab 1Folfox protocol 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoadjuvant Therapy × pembrolizumab × Clear all
NCT05352165 2022-04-28

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Shanghai Minimally Invasive Surgery Center

Phase NA Unknown
192 enrolled

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡